-
公开(公告)号:US08563697B2
公开(公告)日:2013-10-22
申请号:US13058914
申请日:2009-08-14
申请人: Adam William Clarke , Anthony Gerard Doyle , Philip Anthony Jennings , Lynn Dorothy Poulton , Bernadette Wai , Andrew James Pow , George Kopsidas
发明人: Adam William Clarke , Anthony Gerard Doyle , Philip Anthony Jennings , Lynn Dorothy Poulton , Bernadette Wai , Andrew James Pow , George Kopsidas
CPC分类号: C07K16/244 , A61K2039/505 , C07K14/5434 , C07K2317/24 , C07K2317/34 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/622 , C07K2317/76 , C07K2317/92
摘要: The present invention provides an antibody comprising an antigen binding domain which binds to human IL-12 and human IL-23. The antibody binds human IL-12p40 existing as a monomer (human IL-12p40) and as a homodimer (human IL-12p80) and the antibody inhibits the binding of human IL-12 to human IL-12R β2 and human IL-23 to human IL-23R but does not inhibit the binding of human IL-12 or human IL-23 or human IL-12p40 or human IL-12p80 to human IL-12Rβ1.
摘要翻译: 本发明提供了包含结合人IL-12和人IL-23的抗原结合域的抗体。 抗体结合作为单体存在的人IL-12p40(人IL-12p40)和作为同二聚体(人IL-12p80)存在,并且抗体抑制人IL-12与人IL-12Rβ2和人IL-23的结合至 人IL-23R但不抑制人IL-12或人IL-23或人IL-12p40或人IL-12p80与人IL-12Rβ1的结合。
-
公开(公告)号:US20110262445A1
公开(公告)日:2011-10-27
申请号:US13058914
申请日:2009-08-14
申请人: Adam William Clarke , Anthony Gerard Doyle , Philip Jennings , Lynn Dorothy Poulton , Bernadette Wai , Andrew James Pow
发明人: Adam William Clarke , Anthony Gerard Doyle , Philip Jennings , Lynn Dorothy Poulton , Bernadette Wai , Andrew James Pow
IPC分类号: A61K39/395 , C07K1/14 , C07H21/00 , C07H21/04 , C07K1/107 , C12P21/02 , A61P19/02 , A61P19/08 , A61P11/00 , A61P17/06 , A61P25/00 , A61P9/00 , A61P29/00 , A61P9/10 , A61P17/14 , A61P3/00 , A61P25/28 , A61P35/00 , A61P37/08 , A61P3/08 , C07K16/24
CPC分类号: C07K16/244 , A61K2039/505 , C07K14/5434 , C07K2317/24 , C07K2317/34 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/622 , C07K2317/76 , C07K2317/92
摘要: The present invention provides an antibody comprising an antigen binding domain which binds to human IL-12 and human IL-23. The antibody binds human IL-12p40 existing as a monomer (human IL-12p40) and as a homodimer (human IL-12p80) and the antibody inhibits the binding of human IL-12 to human IL-12R β2 and human IL-23 to human IL-23R but does not inhibit the binding of human IL-12 or human IL-23 or human IL-12p40 or human IL-12p80 to human IL-12Rβ1.
摘要翻译: 本发明提供了包含结合人IL-12和人IL-23的抗原结合结构域的抗体。 抗体结合作为单体存在的人IL-12p40(人IL-12p40)和作为同二聚体(人IL-12p80)存在,并且抗体抑制人IL-12与人IL-12R和bgr2和人IL- 23与人IL-23R结合,但不抑制人IL-12或人IL-23或人IL-12p40或人IL-12p80与人IL-12R的结合。
-